Top Markets
Coin of the day
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Rang in Aktien #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Aktienkurs
$0.20342561
Marktkapitalisierung
$1.34M
Veränderung (1 Tag)
-1.44%
Veränderung (1 Jahr)
-65.74%
Land
FR
Handel IntegraGen SA (ALINT)

Kategorie

Preis ALINT mit Marktkapitalisierung von B
IntegraGen SA IntegraGen SA
ALINT
$0.20342561
Marktkapitalisierung von IntegraGen SA(ALINT)
Marktkapitalisierung: $1.34M
Mit Stand July 2026 hat IntegraGen SA eine Marktkapitalisierung von $1.34M. Das macht IntegraGen SA laut unseren Daten zum 19673rd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von IntegraGen SA von 2010 bis 2026
ALINT im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ALINT Vermögenswert B Marktkapitalisierung von B Ergebnisse
IntegraGen SA IntegraGen SA
$724,343 $1.34M
$4.786T +356,072,364.50%
IntegraGen SA IntegraGen SA
$658,336 $1.34M
$4.349T +323,624,881.22%
IntegraGen SA IntegraGen SA
$654,427 $1.34M
$4.324T +321,703,012.19%
IntegraGen SA IntegraGen SA
$432,070 $1.34M
$2.855T +212,396,791.78%
IntegraGen SA IntegraGen SA
$393,533 $1.34M
$2.600T +193,452,778.42%